Dietary Supplements

CHPA appreciates the opportunity to provide comments to the Food and Drug Administration on the proposed experimental study of qualified health claims about omega-3 fatty acids.

The CHPA Dietary Supplements Committee supports maintaining A-priority level for several goals listed in the 2005 Program Priorities that specifically address dietary supplement issues. We also support efforts to fully implement the Dietary Supplement Health and Education Act of 1994 as currently written.

Members of the Consumer Healthcare Products Association appreciate the opportunity to nominate an industry representative to serve on the FDA Food Advisory Committee.

CHPA appreciates the opportunity to provide comments concerning U.S. Government positions in preparation for the 33rd session of the Codex Committee on Food Labelling of the Codex Alimentarius Commission.

CHPA appreciates the opportunity to provide comments on the premarket notification for new dietary ingredient (NDI) notifications for dietary supplements.

Letter to Dr. Saldanha regarding the proposed definition of bioactive food components.

We would like to commend the U.S. Government position previously taken on the vitamin and mineral supplement draft guidelines, and encourage the U.S. Government to maintain a similar position.

CHPA requests CFSAN to commit to the finalization of Good Manufacturing Practices for dietary supplements as one of its highest priorities for FY 2005.